Maryam Lustberg, Director of the Center for Breast Cancer at Yale University School of Medicine, shared on LinkedIn:
” ‘Silent suffering’
Open communication and symptom management interventions are needed for cancer survivors experiencing menopause.”
She also shared a post by Lisa Larkin, Founder and Co-Director of OncoMenopause Consortium:
“Learn more about important differences in the experience of menopause in Black cancer survivors and it can impact adherence and persistence to endocrine therapy.
More sever symptoms – worse adherence and worse cancer outcomes
Symptom management, open communication, awarness of unconscious biases and clinician trust all matter.”
Quoting Lisa Larkin:
“Tonight, the OncoMenopause Consortium is hosting Menopause Myth Busters: Rethinking Inclusive Oncomenopause Care for High-Priority Patient Populations, a live panel built on a premise that’s easy to miss in daily practice: shared decision-making isn’t automatic once a patient is in the room, it depends on who a clinician assumes will speak up, and who they assume won’t.
That gap shows up across breast cancer outcomes, vulvovaginal disease, and menopause care, three areas that rarely get discussed together, and in every one of them, the pattern lands hardest on Black women and other high-priority patients.
Dr. Janeane Anderson, Dr. Sameena Rahman, and Dr. Kudzai Dombo take that pattern on directly, looking at the assumptions clinicians make about who advocates for their own care and what changes once those assumptions get corrected.
It’s free to watch live, 8 to 9 pm ET, and built for anyone practicing in women’s health, oncology, or primary care.
I hope you can join us! Learn more or register.”
Title: Racial Differences in Patient-Reported Symptoms and Adherence to Adjuvant Endocrine Therapy Among Women With Early-Stage, Hormone Receptor–Positive Breast Cancer
Authors: Xin Hu, Mark S. Walker, Edward Stepanski, Cameron M. Kaplan, Michelle Y. Martin, Gregory A. Vidal, Lee S. Schwartzberg, Ilana Graetz
Read the full article.
You can also read: Tissue-Free ctDNA Detects MRD Before TNBC Recurrence
